rs758187

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001146312.3(MYOCD):​c.-435T>C variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 158,126 control chromosomes in the GnomAD database, including 13,770 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.38 ( 13574 hom., cov: 33)
Exomes 𝑓: 0.23 ( 196 hom. )

Consequence

MYOCD
NM_001146312.3 upstream_gene

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.664

Publications

1 publications found
Variant links:
Genes affected
MYOCD (HGNC:16067): (myocardin) This gene encodes a nuclear protein, which is expressed in heart, aorta, and in smooth muscle cell-containing tissues. It functions as a transcriptional co-activator of serum response factor (SRF) and modulates expression of cardiac and smooth muscle-specific SRF-target genes, and thus may play a crucial role in cardiogenesis and differentiation of the smooth muscle cell lineage. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
MYOCD Gene-Disease associations (from GenCC):
  • megabladder, congenital
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-12665754-T-C is Benign according to our data. Variant chr17-12665754-T-C is described in ClinVar as Benign. ClinVar VariationId is 1253022.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.668 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYOCDNM_001146312.3 linkc.-435T>C upstream_gene_variant ENST00000425538.6 NP_001139784.1 Q8IZQ8-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYOCDENST00000425538.6 linkc.-435T>C upstream_gene_variant 1 NM_001146312.3 ENSP00000401678.1 Q8IZQ8-3
MYOCDENST00000579237.5 linkn.-435T>C upstream_gene_variant 4 ENSP00000462694.1 J3KSX3

Frequencies

GnomAD3 genomes
AF:
0.380
AC:
57738
AN:
152024
Hom.:
13526
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.674
Gnomad AMI
AF:
0.224
Gnomad AMR
AF:
0.358
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.249
Gnomad SAS
AF:
0.211
Gnomad FIN
AF:
0.294
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.353
GnomAD4 exome
AF:
0.232
AC:
1391
AN:
5984
Hom.:
196
AF XY:
0.229
AC XY:
692
AN XY:
3020
show subpopulations
African (AFR)
AF:
0.629
AC:
156
AN:
248
American (AMR)
AF:
0.348
AC:
62
AN:
178
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
62
AN:
274
East Asian (EAS)
AF:
0.190
AC:
69
AN:
364
South Asian (SAS)
AF:
0.217
AC:
20
AN:
92
European-Finnish (FIN)
AF:
0.203
AC:
39
AN:
192
Middle Eastern (MID)
AF:
0.250
AC:
10
AN:
40
European-Non Finnish (NFE)
AF:
0.210
AC:
883
AN:
4206
Other (OTH)
AF:
0.231
AC:
90
AN:
390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.380
AC:
57847
AN:
152142
Hom.:
13574
Cov.:
33
AF XY:
0.378
AC XY:
28125
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.675
AC:
28008
AN:
41516
American (AMR)
AF:
0.359
AC:
5490
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
946
AN:
3468
East Asian (EAS)
AF:
0.250
AC:
1282
AN:
5132
South Asian (SAS)
AF:
0.210
AC:
1010
AN:
4820
European-Finnish (FIN)
AF:
0.294
AC:
3116
AN:
10604
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.250
AC:
16963
AN:
67978
Other (OTH)
AF:
0.350
AC:
741
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1611
3223
4834
6446
8057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.317
Hom.:
1257
Bravo
AF:
0.403
Asia WGS
AF:
0.229
AC:
799
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 18028454) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
8.2
DANN
Benign
0.32
PhyloP100
-0.66
PromoterAI
0.025
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs758187; hg19: chr17-12569071; API